Emile Voest

Emile Voest

Director/Board Member at SANOFI

64 year
Health Technology
Consumer Services
Health Services

Profile

Emile Voest is the founder of the Hartwig Medical Foundation, founded in 2015, where he holds the title of Non-Executive Director.
He was also the founder of the Hubrecht Organoid Technology Foundation, founded in 2013, where he held the title of Medical Director from 2013 to 2016.
Additionally, Dr. Voest is the founder of the Center For Personalized Cancer Therapy, founded in 2010, where he currently serves as Director.
Dr. Voest's current job(s) include being an Independent Director at Sanofi since 2022 and a Professor at the University of Utrecht since 1999.
Dr. Voest's former job(s) include being the Director of the European Society for Medical Oncology from 2015 to 2020 and the Executive Medical Director of Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh from 2014 to 2020.
Dr. Voest obtained a doctorate degree from the University of Utrecht.

Emile Voest active positions

CompaniesPositionStart
SANOFI Director/Board Member 02/05/2022
Hartwig Medical Foundation Founder 31/12/2014
Center For Personalized Cancer Therapy Founder 31/12/2009
University of Utrecht Corporate Officer/Principal 31/12/1998
All active positions of Emile Voest

Former positions of Emile Voest

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 31/12/2019
Director/Board Member 31/12/2019
Hubrecht Organoid Technology Foundation Founder 31/12/2015
See the detail of Emile Voest's experience

Training of Emile Voest

University of Utrecht Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emile Voest's experience

Connections

98

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
SANOFI

Health Technology

Private companies5

Health Services

Miscellaneous

Hubrecht Organoid Technology Foundation

Hartwig Medical Foundation

Center For Personalized Cancer Therapy

See company connections